Skip to main navigation Skip to search Skip to main content

"Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adolescents and Adults Aged 10 to 55 Years"

  • Fling, John (PI)

Project Details

StatusFinished
Effective start/end date10/06/1610/06/21

Funding

  • Sanofi Pasteur, Inc.: $97,325.00

Keywords

  • Biotechnology & Drug Development, Other